Indeed, recent observations have raised the possibility of the application of radioiodine therapy to breast cancer and other cancers by the introduction of NIS into tumors via viral vectors or upregulating the tumors’ endogenous NIS expression, if present. This evidence concerns the gene SLC5A5 and cancer.